Translation and validation of the cardiac rehabilitation barriers scale in the Czech Republic (CRBS-CZE): Protocol to determine the key barriers in East-Central Europe.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 24 3 2020
Statut: ppublish

Résumé

Cardiovascular diseases are highly prevalent and represent leading causes of morbidity worldwide, including in Central Europe. Cardiac rehabilitation (CR) is an effective method of secondary prevention, but utilization is low. Barriers to CR use in the Czech Republic are not well-characterized, and therefore we propose a protocol to translate and validate the cardiac rehabilitation barriers scale (CRBS). In this multi-method study, we translated and cross-culturally validated the CRBS to Czech (CRBS-CZE) first through the following main steps: professional translation, reconciliation/harmonization, and cross-cultural adaptation, and piloting in 50 cardiac patients. A prospective study will be undertaken to psychometrically-validate the CRBS-CZE, where 300 to 600 cardiac inpatients eligible for phase II/outpatient CR will be recruited. Consenting participants will be informed about the CR program and their sociodemographic, clinical characteristics, and the CRBS-CZE administered. Factor analysis will be performed with oblique rotation, factors will be extracted based on eigenvalues, the examination of the scree plot, and factor loadings. The internal reliability of the total scale and subscales will be assessed with Cronbach alpha. Overall CRBS scores will be compared by patient characteristics such as sex, socioeconomic indicators, risk factor burden, and travel time to investigate content validity. Their CR enrollment, adherence (% of 24 prescribed sessions attended), and completion will be tracked. The second administration of CRBS-CZE will be undertaken in patients at 3 weeks after enrollment. To test criterion validity, t tests and Pearson correlation (for adherence) will be used to determine the association of these utilization indicators with CRBS scores. The translated version was considered by 2 bilingual CR experts. Some revisions and example additions were made to the items. Upon piloting with patients, some further edits were made. No additional barriers were raised. Through this study, a reliable and valid means of assessing patient's CR barriers will be established. Results will be used to identify ways to help patients overcome barriers to CR utilization.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular diseases are highly prevalent and represent leading causes of morbidity worldwide, including in Central Europe. Cardiac rehabilitation (CR) is an effective method of secondary prevention, but utilization is low. Barriers to CR use in the Czech Republic are not well-characterized, and therefore we propose a protocol to translate and validate the cardiac rehabilitation barriers scale (CRBS).
METHODS METHODS
In this multi-method study, we translated and cross-culturally validated the CRBS to Czech (CRBS-CZE) first through the following main steps: professional translation, reconciliation/harmonization, and cross-cultural adaptation, and piloting in 50 cardiac patients. A prospective study will be undertaken to psychometrically-validate the CRBS-CZE, where 300 to 600 cardiac inpatients eligible for phase II/outpatient CR will be recruited. Consenting participants will be informed about the CR program and their sociodemographic, clinical characteristics, and the CRBS-CZE administered. Factor analysis will be performed with oblique rotation, factors will be extracted based on eigenvalues, the examination of the scree plot, and factor loadings. The internal reliability of the total scale and subscales will be assessed with Cronbach alpha. Overall CRBS scores will be compared by patient characteristics such as sex, socioeconomic indicators, risk factor burden, and travel time to investigate content validity. Their CR enrollment, adherence (% of 24 prescribed sessions attended), and completion will be tracked. The second administration of CRBS-CZE will be undertaken in patients at 3 weeks after enrollment. To test criterion validity, t tests and Pearson correlation (for adherence) will be used to determine the association of these utilization indicators with CRBS scores.
RESULTS RESULTS
The translated version was considered by 2 bilingual CR experts. Some revisions and example additions were made to the items. Upon piloting with patients, some further edits were made. No additional barriers were raised.
DISCUSSION CONCLUSIONS
Through this study, a reliable and valid means of assessing patient's CR barriers will be established. Results will be used to identify ways to help patients overcome barriers to CR utilization.

Identifiants

pubmed: 32176110
doi: 10.1097/MD.0000000000019546
pii: 00005792-202003130-00087
pmc: PMC7440137
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e19546

Références

Circulation. 2011 Nov 29;124(22):2458-73
pubmed: 22052934
Can J Cardiol. 2014 Aug;30(8):945-8
pubmed: 25064585
Hellenic J Cardiol. 2019 Jan - Feb;60(1):66-67
pubmed: 31121266
Glob Heart. 2017 Dec;12(4):323-334.e10
pubmed: 28302548
Ann Rehabil Med. 2018 Feb;42(1):154-165
pubmed: 29560336
Eur J Prev Cardiol. 2018 Jan;25(1):54-64
pubmed: 28812915
Eur J Prev Cardiol. 2013 Aug;20(4):692-700
pubmed: 23847263
Medicine (Baltimore). 2018 Sep;97(37):e12385
pubmed: 30213005
J Clin Med. 2019 Feb 05;8(2):
pubmed: 30764517
J Nurs Res. 2020 Feb;28(1):e64
pubmed: 31107774
Med Sci Monit. 2019 Jul 07;25:5015-5027
pubmed: 31280281
Implement Sci. 2012 Dec 13;7:120
pubmed: 23234558
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
Eur J Prev Cardiol. 2012 Jun;19(3):494-503
pubmed: 22779092
Clin Rehabil. 2012 Feb;26(2):152-64
pubmed: 21937522
Am Heart J. 2012 Dec;164(6):835-45.e2
pubmed: 23194483
Cent Eur J Public Health. 2015 Sep;23(3):208-13
pubmed: 26615651
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
J Cardiopulm Rehabil Prev. 2020 Mar;40(2):79-86
pubmed: 31764535
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Arq Bras Cardiol. 2012 Apr;98(4):344-51
pubmed: 22426990
Int J Cardiol. 2016 Nov 15;223:436-443
pubmed: 27557484
Eur J Cardiovasc Nurs. 2019 Apr;18(4):260-271
pubmed: 30667278
J Clin Epidemiol. 1998 Nov;51(11):913-23
pubmed: 9817108
Eur Heart J. 2015 May 14;36(19):1163-70
pubmed: 25586123
Circulation. 2016 Mar 1;133(9):916-47
pubmed: 26811316
J Clin Med. 2018 Dec 04;7(12):
pubmed: 30518047

Auteurs

Petr Winnige (P)

Department of Rehabilitation, University Hospital Brno.
Department of Public Health, Faculty of Medicine, Masaryk University Brno.

Ladislav Batalik (L)

Department of Rehabilitation, University Hospital Brno.
Department of Internal Cardiology Medicine, University Hospital Brno, Brno, Czech Republic.

Katerina Filakova (K)

Department of Rehabilitation, University Hospital Brno.

Jakub Hnatiak (J)

Department of Rehabilitation, University Hospital Brno.

Filip Dosbaba (F)

Department of Rehabilitation, University Hospital Brno.

Sherry L Grace (SL)

Faculty of Health, York University & University Health Network, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH